Structure Therapeutics, Inc. (GPCR)
21.94
+0.46
(+2.14%)
USD |
NASDAQ |
Oct 29, 16:00
22.18
+0.24
(+1.09%)
After-Hours: 04:29
Structure Therapeutics Shareholders Equity (Quarterly) : 1.354B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.354B |
| March 31, 2026 | 1.447B |
| December 31, 2025 | 1.516B |
| September 30, 2025 | 770.02M |
| June 30, 2025 | 772.09M |
| March 31, 2025 | 824.65M |
| December 31, 2024 | 864.84M |
| September 30, 2024 | 896.81M |
| June 30, 2024 | 921.06M |
| March 31, 2024 | 429.81M |
| Date | Value |
|---|---|
| December 31, 2023 | 452.97M |
| September 30, 2023 | 192.96M |
| June 30, 2023 | 214.41M |
| March 31, 2023 | 236.35M |
| December 31, 2022 | 84.84M |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | 102.22M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Eli Lilly & Co. | 40.27B |
| Novo Nordisk A/S | 33.84B |
| Pfizer Inc. | 85.19B |
| Viking Therapeutics, Inc. | 588.60M |
| Liquidia Corp. | 195.11M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.425B |
| Total Liabilities (Quarterly) | 71.01M |
| Debt to Equity Ratio | 0.0046 |
| Current Ratio | 20.75 |
| Net Debt Paydown Yield | 0.01% |